Business - March 8, 2023
New report: The status of Swedish drug development
A new report from industry organization SwedenBIO shows that Swedish pharmaceutical manufacturing and research remains strong and the country continues to be a prominent player in life sciences. The Swedish Drug Discovery and Development Pipeline report is produced every three years and is the only one of its kind. It maps the drug projects under […]
Business - March 8, 2023
Oncopeptides CSO investigated for violation of the Market Abuse Act
Oncopeptides has been informed by the Swedish Economic Crime Authority that the CSO Jakob Lindberg has been arrested for a suspected violation of the Market Abuse Act (Sw. lag om straff för marknadsmissbruk på värdepappersmarknaden). The company does currently not have any additional information but will provide an update to the market when we have […]
Business - February 28, 2023
The waste of one – the raw material of the other
At Orion Pharma’s Fermion plant waste ethanol is used to reduce the nitrogen load in the Baltic Sea. Outside Hanko in Finland, two different plants are located side-by-side. One of them is Orion’s subsidiary Fermion, manufacturing pharmaceutical ingredients, and the other is the Dupont-owned Genencor International, manufacturing enzymes. The two plants decided to work together […]
Business - February 15, 2023
New partnership for easier access to China
The Danish Life Science Cluster and the Ministry of Foreign Affairs of Denmark have established a new partnership to create easier access to China for Danish companies within medtech, healthtech and rehabilitation – with a special focus on a designated specialty medical zone. Danish Life Science Cluster, Innovation Center Denmark in Shanghai, The Trade Council […]
Business - February 1, 2023
Last patient included in AlzeCure’s Phase II trial
The last patient has now been included in the ongoing clinical study with ACD440, the lead non-opioid drug candidate in the painless platform, which is being developed against peripheral neuropathic pain. This double-blind, placebo-controlled, randomized cross-over study, which is carried out in collaboration with LINK Medical Research in Uppsala, is aimed at evaluating the efficacy, […]
Business - February 1, 2023
An export success anchored in Umeå & Linköping
Nordic Biomarker was recently named ‘Exporter of the Year 2022’ but the Umeå-based company says its journey has only just begun. The company has announced its vision to become a global force in the life science industry – with an ambitious five-year goal to reach almost a 1 billion SEK turnover and potentially employ over […]
